🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 08 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Kansas

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

10
Recruiting now
12
Studies tracked
Kansas
Selected state
Recruiting Phase 3
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC · started 2013-09-09
📍 California · Connecticut · Georgia · Illinois · Indiana · Kansas · Kentucky · Massachusetts
NCT01804686 on ClinicalTrials.gov ↗
Active Phase 3
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC · started 2024-04-09
📍 Arkansas · California · Colorado · Florida · Illinois · Indiana · Kansas · Michigan
NCT06211764 on ClinicalTrials.gov ↗
Recruiting Phase 2
Crohn Disease
Eli Lilly and Company · started 2026-05-04
📍 Arizona · California · Colorado · Florida · Georgia · Illinois · Kansas · Michigan
NCT07483099 on ClinicalTrials.gov ↗
Recruiting
Coronary Artery Disease
Teleflex · started 2025-07-18
📍 California · Kansas · Massachusetts · Missouri · New York · Texas · West Virginia
NCT06779630 on ClinicalTrials.gov ↗
Recruiting Phase 3
Multiple Sclerosis (MS) Primary Progressive
Zenas BioPharma (USA), LLC · started 2026-03-23
📍 Arizona · California · Florida · Kansas · Missouri · North Carolina · Ohio · South Carolina
NCT07067463 on ClinicalTrials.gov ↗
Recruiting Phase 3
Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Revolution Medicines, Inc. · started 2025-12-15
📍 California · Colorado · Connecticut · Florida · Georgia · Indiana · Kansas · Maryland
NCT07252232 on ClinicalTrials.gov ↗
Active Phase 2
Amyotrophic Lateral Sclerosis (ALS)
Novartis Pharmaceuticals · started 2024-10-17
📍 California · Florida · Georgia · Kansas · Massachusetts · Nebraska · New York · North Carolina
NCT06643481 on ClinicalTrials.gov ↗
Recruiting Phase 3
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company · started 2024-04-29
📍 Alabama · Arizona · California · Colorado · Florida · Idaho · Illinois · Kansas
NCT06338995 on ClinicalTrials.gov ↗
Recruiting Phase 2
Microvascular Inflammation
Biogen · started 2026-01-05
📍 California · Kansas · Michigan · Minnesota · Missouri · Nebraska · New Jersey · North Carolina
NCT07219043 on ClinicalTrials.gov ↗
Recruiting Phase 2
Colitis, Ulcerative, Crohn Disease
Eli Lilly and Company · started 2026-05-04
📍 Arizona · California · Colorado · Florida · Georgia · Illinois · Kansas · Michigan
NCT07483073 on ClinicalTrials.gov ↗
Recruiting Phase 3
Osteoarthritis
Eli Lilly and Company · started 2025-09-15
📍 Arizona · California · Colorado · Connecticut · Georgia · Illinois · Kansas · Massachusetts
NCT07153471 on ClinicalTrials.gov ↗
Recruiting
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Bayer · started 2020-04-03
📍 Arizona · California · Colorado · Connecticut · Florida · Indiana · Kansas · Maine
NCT04142437 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 125 Florida · 104 Georgia · 66 Illinois · 58 Arizona · 57 Colorado · 55 Connecticut · 41 Michigan · 38 Indiana · 37 Alabama · 37 Massachusetts · 36 Texas · 35 New York · 32 Maryland · 27 Ohio · 24 Arkansas · 22

Browse by condition

Obesity · 7 Overweight · 6 Advanced Solid Tumors · 5 Neoplasm Metastasis · 4 Colitis, Ulcerative · 4 Melanoma · 3 Non-small Cell Lung Cancer · 3 Alzheimer Disease · 3 Crohn Disease · 3 Schizophrenia · 3 Small Lymphocytic Lymphoma · 2 Follicular Lymphoma · 2 Osteoarthritis · 2 Overweight or Obesity · 2 Alzheimers Disease · 2 Diabetes Mellitus, Type 1 · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/kansas (Accessed: 8 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.